Cargando…
Dopaminergic Modulation of Medial Prefrontal Cortex Deactivation in Parkinson Depression
Parkinson's disease (PD) is associated with emotional abnormalities. Dopaminergic medications ameliorate Parkinsonian motor symptoms, but less is known regarding the impact of dopaminergic agents on affective processing, particularly in depressed PD (dPD) patients. The aim of this study was to...
Autores principales: | Andersen, Anders H., Smith, Charles D., Slevin, John T., Kryscio, Richard J., Martin, Catherine A., Schmitt, Frederick A., Blonder, Lee X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697088/ https://www.ncbi.nlm.nih.gov/pubmed/26793404 http://dx.doi.org/10.1155/2015/513452 |
Ejemplares similares
-
Anterior Medial Prefrontal Cortex Exhibits Activation during Task Preparation but Deactivation during Task Execution
por: Koshino, Hideya, et al.
Publicado: (2011) -
Emotional Dysfunction in Parkinson’s Disease
por: Blonder, Lee X., et al.
Publicado: (2011) -
Dopaminergic modulation of appetitive trace conditioning: the role of D1 receptors in medial prefrontal cortex
por: Pezze, M. A., et al.
Publicado: (2015) -
Dopaminergic Modulation of Prefrontal Cortex Inhibition
por: Di Domenico, Danila, et al.
Publicado: (2023) -
Thiamine tetrahydrofurfuryl disulfide promotes voluntary activity through dopaminergic activation in the medial prefrontal cortex
por: Saiki, Masato, et al.
Publicado: (2018)